A
Alnylam Pharmaceuticals, Inc. (ALNY)
NMS – Real vaqt narxi. Valyuta: USD
223.95
+2.75 (1.24%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
223.95
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:04 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
223.95
+2.75 (1.24%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
223.95
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:04 PM EDT
This stock has a consensus price target of $430.10 based on the ratings of 32 analysts. The high is $583.00 and the low is $300.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 300 | $ 430.1 | $ 583 |
| O’zgarish | 35.62% | 94.44% | 163.56% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-08-03 | 89.14% | Raymond James | $420 → $420 | Upgrades | Outperform → Strong Buy |
| 2026-08-03 | 53.11% | Citigroup | $380 → $340 | Maintains | Buy |
| 2026-08-03 | 102.65% | Barclays | $527 → $450 | Maintains | Overweight |
| 2026-07-31 | 68.87% | JP Morgan | $400 → $375 | Maintains | Overweight |
| 2026-07-31 | 57.61% | RBC Capital | $445 → $350 | Maintains | Outperform |